• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丁螺环酮治疗酒精依赖:一项安慰剂对照试验。

Buspirone in the treatment of alcohol dependence: a placebo-controlled trial.

作者信息

Malec E, Malec T, Gagné M A, Dongier M

机构信息

Douglas Hospital Research Center, Alcohol Research Program, Montreal, Quebec, Canada.

出版信息

Alcohol Clin Exp Res. 1996 Apr;20(2):307-12. doi: 10.1111/j.1530-0277.1996.tb01644.x.

DOI:10.1111/j.1530-0277.1996.tb01644.x
PMID:8730222
Abstract

A double-blind controlled study of the effects of buspirone on alcohol dependence and associated symptoms in ambulatory alcoholics showed a marked improvement in both treatment and control groups. However, significant differences in favor of the medication were observed in several psychopathological measures, but not in measures of alcohol consumption. Contrary to a majority of prior controlled trials of buspirone in alcoholics, subjects were not selected on the basis of comorbid generalized anxiety; rather, the study tested the hypothesis of a direct effect on craving and consumption, independent from an anxiolytic effect. This hypothesis was not confirmed.

摘要

一项关于丁螺环酮对非住院酗酒者酒精依赖及相关症状影响的双盲对照研究显示,治疗组和对照组均有显著改善。然而,在几项精神病理学指标上观察到有利于该药物的显著差异,但在酒精摄入量指标上未观察到。与之前大多数针对酗酒者的丁螺环酮对照试验不同,该研究并非基于共病广泛性焦虑来选择受试者;相反,该研究检验了丁螺环酮对渴望和饮酒量有直接影响(独立于抗焦虑作用)这一假设。这一假设未得到证实。

相似文献

1
Buspirone in the treatment of alcohol dependence: a placebo-controlled trial.丁螺环酮治疗酒精依赖:一项安慰剂对照试验。
Alcohol Clin Exp Res. 1996 Apr;20(2):307-12. doi: 10.1111/j.1530-0277.1996.tb01644.x.
2
Efficacy of buspirone in alcohol dependence: a review.丁螺环酮治疗酒精依赖的疗效:综述
Alcohol Clin Exp Res. 1996 Aug;20(5):853-8. doi: 10.1111/j.1530-0277.1996.tb05263.x.
3
A placebo-controlled trial of buspirone in anxious inpatient alcoholics.一项针对焦虑住院酒精成瘾者的丁螺环酮安慰剂对照试验。
Alcohol Clin Exp Res. 1992 Dec;16(6):1007-13. doi: 10.1111/j.1530-0277.1992.tb00691.x.
4
Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone).用一种选择性5-羟色胺能药物(丁螺环酮)治疗近期戒酒的酒精依赖人群中的共病广泛性焦虑症。
J Clin Psychopharmacol. 1992 Feb;12(1):19-26. doi: 10.1097/00001573-199202000-00004.
5
Buspirone augmentation of a selective serotonin reuptake inhibitor: efficacy in two depressed patients with comorbid anxiety and type I alcohol dependence.丁螺环酮增强选择性5-羟色胺再摄取抑制剂:对两名伴有共病焦虑和I型酒精依赖的抑郁症患者的疗效
J Clin Psychopharmacol. 1997 Oct;17(5):425-6. doi: 10.1097/00004714-199710000-00014.
6
Buspirone treatment of anxious alcoholics. A placebo-controlled trial.丁螺环酮治疗焦虑型酗酒者:一项安慰剂对照试验。
Arch Gen Psychiatry. 1994 Sep;51(9):720-31. doi: 10.1001/archpsyc.1994.03950090052008.
7
A multicentre double-blind comparison of hydroxyzine, buspirone and placebo in patients with generalized anxiety disorder.羟嗪、丁螺环酮与安慰剂治疗广泛性焦虑障碍的多中心双盲对照研究
Psychopharmacology (Berl). 1998 Oct;139(4):402-6. doi: 10.1007/s002130050731.
8
Pharmacological treatments for alcoholism: revisiting lithium and considering buspirone.酒精成瘾的药物治疗:重新审视锂盐并考虑丁螺环酮。
Alcohol Clin Exp Res. 2000 May;24(5):666-74.
9
Buspirone in the treatment of alcoholic patients.丁螺环酮用于酒精成瘾患者的治疗。
Psychopathology. 1989;22 Suppl 1:49-59. doi: 10.1159/000284626.
10
The association of buspirone and its metabolite 1-pyrimidinylpiperazine in the remission of comorbid anxiety with depressive features and alcohol dependency.丁螺环酮及其代谢物1-嘧啶基哌嗪在缓解伴有抑郁特征的共病焦虑和酒精依赖中的关联。
Psychopharmacol Bull. 1991;27(2):163-70.

引用本文的文献

1
Pharmacological Treatment of Alcohol Cravings.酒精渴望的药物治疗。
Brain Sci. 2023 Aug 15;13(8):1206. doi: 10.3390/brainsci13081206.
2
Efficacy of pharmacotherapeutics for patients comorbid with alcohol use disorders and depressive symptoms-A bayesian network meta-analysis.伴有酒精使用障碍和抑郁症状患者的药物治疗效果:一项贝叶斯网络荟萃分析。
CNS Neurosci Ther. 2020 Nov;26(11):1185-1197. doi: 10.1111/cns.13437. Epub 2020 Jul 19.
3
Dopamine D3 receptor-based medication development for the treatment of opioid use disorder: Rationale, progress, and challenges.
基于多巴胺D3受体的药物开发用于治疗阿片类物质使用障碍:理论依据、进展与挑战。
Neurosci Biobehav Rev. 2020 Jul;114:38-52. doi: 10.1016/j.neubiorev.2020.04.024. Epub 2020 May 3.
4
Treatment for Substance Use Disorder With Co-Occurring Mental Illness.共病精神疾病的物质使用障碍治疗
Focus (Am Psychiatr Publ). 2019 Apr;17(2):88-97. doi: 10.1176/appi.focus.20180042. Epub 2019 Apr 10.
5
5-HT1A receptor-dependent modulation of emotional and neurogenic deficits elicited by prolonged consumption of alcohol.5-HT1A 受体依赖性调制延长酒精摄入引起的情绪和神经源性缺陷。
Sci Rep. 2018 Feb 1;8(1):2099. doi: 10.1038/s41598-018-20504-z.
6
Relapse Prevention in Alcoholism : Recent Advances and Future Possibilities.酒精中毒复发预防:最新进展和未来可能。
CNS Drugs. 1997 Apr;7(4):313-27. doi: 10.2165/00023210-199707040-00004.
7
Pharmacotherapy for alcohol use disorder: current and emerging therapies.酒精使用障碍的药物治疗:当前及新兴疗法
Harv Rev Psychiatry. 2015 Mar-Apr;23(2):122-33. doi: 10.1097/HRP.0000000000000079.
8
Substance use disorders and anxiety: a treatment challenge for social workers.物质使用障碍与焦虑:社会工作者面临的治疗挑战。
Soc Work Public Health. 2013;28(3-4):407-23. doi: 10.1080/19371918.2013.774675.
9
Evaluation of buspirone for relapse-prevention in adults with cocaine dependence: an efficacy trial conducted in the real world.评估丁螺环酮预防成人可卡因依赖复发的疗效:一项在真实世界中进行的疗效试验。
Contemp Clin Trials. 2012 Sep;33(5):993-1002. doi: 10.1016/j.cct.2012.05.003. Epub 2012 May 19.
10
Anxiety Disorders with Comorbid Substance Use Disorders: Diagnostic and Treatment Considerations.伴有物质使用障碍共病的焦虑症:诊断与治疗考量
Psychiatr Ann. 2008 Nov;38(11):724-729. doi: 10.3928/00485713-20081101-01.